Zacks Research Research Analysts Lift Earnings Estimates for Prestige Consumer Healthcare Inc. (NYSE:PBH)

Prestige Consumer Healthcare Inc. (NYSE:PBH) – Equities researchers at Zacks Research lifted their FY2024 earnings per share estimates for shares of Prestige Consumer Healthcare in a report issued on Monday, April 22nd. Zacks Research analyst R. Department now expects that the company will earn $4.33 per share for the year, up from their prior estimate of $4.32. The consensus estimate for Prestige Consumer Healthcare’s current full-year earnings is $4.33 per share. Zacks Research also issued estimates for Prestige Consumer Healthcare’s Q4 2024 earnings at $1.14 EPS, Q4 2026 earnings at $1.20 EPS and FY2026 earnings at $4.75 EPS.

Several other equities analysts have also commented on PBH. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, February 10th. TheStreet upgraded Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research report on Monday, February 12th. One investment analyst has rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, Prestige Consumer Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.00.

Prestige Consumer Healthcare Stock Performance

NYSE:PBH opened at $71.23 on Tuesday. The business’s 50-day moving average price is $70.83 and its two-hundred day moving average price is $64.03. Prestige Consumer Healthcare has a twelve month low of $55.96 and a twelve month high of $75.31. The stock has a market cap of $3.54 billion, a P/E ratio of -43.43, a PEG ratio of 1.89 and a beta of 0.52. The company has a quick ratio of 1.92, a current ratio of 3.09 and a debt-to-equity ratio of 0.75.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, February 8th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.02. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. The firm had revenue of $282.74 million for the quarter, compared to analysts’ expectations of $280.25 million. During the same quarter last year, the firm posted $1.04 EPS. The company’s revenue was up 2.6% compared to the same quarter last year.

Insider Activity

In other news, SVP Mary Beth Fritz sold 5,336 shares of the stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $69.00, for a total transaction of $368,184.00. Following the transaction, the senior vice president now directly owns 15,934 shares in the company, valued at approximately $1,099,446. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On Prestige Consumer Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Sequoia Financial Advisors LLC grew its position in Prestige Consumer Healthcare by 1.8% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 10,068 shares of the company’s stock worth $576,000 after acquiring an additional 179 shares during the last quarter. Pinnacle Associates Ltd. grew its position in Prestige Consumer Healthcare by 0.8% during the 3rd quarter. Pinnacle Associates Ltd. now owns 24,672 shares of the company’s stock worth $1,411,000 after acquiring an additional 200 shares during the last quarter. Pacer Advisors Inc. grew its position in Prestige Consumer Healthcare by 85.7% during the 4th quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock worth $27,000 after acquiring an additional 204 shares during the last quarter. Parallel Advisors LLC grew its position in Prestige Consumer Healthcare by 42.5% during the 4th quarter. Parallel Advisors LLC now owns 714 shares of the company’s stock worth $44,000 after acquiring an additional 213 shares during the last quarter. Finally, Global Retirement Partners LLC grew its position in shares of Prestige Consumer Healthcare by 22.6% in the 3rd quarter. Global Retirement Partners LLC now owns 1,364 shares of the company’s stock worth $78,000 after buying an additional 251 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.